Bovine Respiratory Disease Complex: Diagnostic Approaches

Introduction

Bovine Respiratory Disease Complex (BRDC) represents a multifactorial syndrome with significant economic impact on the beef and dairy industries globally. The condition arises from an interaction between host stress factors, viral predisposing agents, and bacterial pathogens. The bacterial component of BRDC is primarily driven by a consortium of opportunistic pathogens including Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and to a lesser extent Trueperella pyogenes and Mycoplasma bovis. Accurate and timely diagnosis of these bacterial agents is essential for effective treatment, control, and implementation of antimicrobial stewardship programs. This article reviews the diagnostic approaches for the primary bacterial pathogens involved in BRDC, with a focus on culture-based methods, molecular techniques, serological assays, and the role of antimicrobial susceptibility testing.

Bacterial Pathogens of BRDC

Mannheimia haemolytica

Mannheimia haemolytica, formerly classified as Pasteurella haemolytica, is the most frequently isolated bacterial pathogen from cases of fibrinous pneumonia in feedlot cattle. Serotype A1 is predominant in North America, while serotypes A2 and A6 are also commonly identified. The primary virulence factor is a leukotoxin (LktA) belonging to the repeats-in-toxin (RTX) family. LktA specifically targets ruminant leukocytes and platelets, inducing cell lysis and triggering an intense inflammatory response that characterizes the fibrinous and necrotic lung lesions observed in acute BRDC [1, 2]. Additional virulence determinants include adhesins, a polysaccharide capsule, and iron acquisition systems that facilitate survival within the host respiratory tract [3].

Pasteurella multocida

Pasteurella multocida is a commensal of the upper respiratory tract in cattle and is frequently isolated from cases of bronchopneumonia. Capsular serogroups A and D are most commonly associated with bovine respiratory disease. The organism produces a polysaccharide capsule that inhibits phagocytosis and a dermonecrotic toxin (PMT) that modulates host cell signaling pathways. While P. multocida is often isolated from pneumonic lungs, its role as a primary pathogen in BRDC is debated; it is frequently considered a secondary invader following viral infection or stress-induced immunosuppression [4, 5]. Avian Cholera in Waterfowl provides a comparative perspective on P. multocida pathogenesis in avian species, though the serotypes and disease manifestations differ from bovine infections.

Histophilus somni

Histophilus somni, previously known as Haemophilus somnus, is a Gram-negative coccobacillus that causes a range of clinical manifestations including pneumonia, myocarditis, thrombotic meningoencephalitis, and polyarthritis in cattle. The organism expresses a phase-variable lipooligosaccharide (LOS) that undergoes antigenic variation and a biofilm-forming capacity that contributes to persistence within the host [6, 7]. H. somni also produces an immunoglobulin-binding protein (IbpA) and a fibronectin-binding protein (FbpA) that facilitate adherence to respiratory epithelium and extracellular matrix components [8].

Mycoplasma bovis

Mycoplasma bovis is an important component of BRDC, particularly in chronic, treatment-resistant cases. The organism lacks a cell wall, rendering beta-lactam antibiotics ineffective. M. bovis produces a polysaccharide capsule and variable surface lipoproteins that undergo high-frequency phase variation, contributing to immune evasion [9]. Chronic infections are characterized by caseonecrotic bronchopneumonia with characteristic luminal necrosis and lymphoid hyperplasia. The diagnostic challenges associated with M. bovis are substantial due to its fastidious growth requirements and slow replication rate. A detailed discussion of M. bovis diagnostics is presented in Mycoplasma bovis in Feedlot Cattle: Chronic Pneumonia, Arthritis, and the Challenge of Cultivation versus Molecular Detection.

Diagnostic Approaches

Clinical and Postmortem Assessment

Clinical diagnosis of BRDC is based on the observation of fever (temperature exceeding 40.0 degrees Celsius), depression, anorexia, nasal discharge, dyspnea, and tachypnea. A standardized clinical scoring system, such as the DART (Depression, Appetite, Respiratory, Temperature) system, is used to identify candidate animals for treatment. However, clinical signs alone lack specificity for bacterial etiology and correlate poorly with microbiological findings [10, 11].

Postmortem examination provides a macroscopic assessment of pneumonia severity and distribution. Fibrinous pleuritis, cranioventral consolidation, and interlobular edema are consistent with M. haemolytica infection. Histopathology reveals coagulative necrosis, fibrin thrombi, and neutrophil infiltration. H. somni infection frequently presents with a characteristic myocarditis and meningitis in addition to pneumonia [12, 13].

Culture-Based Techniques

Bacterial culture remains a cornerstone of BRDC diagnosis. Samples from live animals include deep nasopharyngeal swabs, transtracheal washes, and bronchoalveolar lavage fluid. Postmortem samples include lung tissue collected aseptically from the interface between normal and consolidated parenchyma.

M. haemolytica and P. multocida grow readily on blood agar and MacConkey agar under aerobic conditions at 37 degrees Celsius overnight. H. somni requires enriched media such as chocolate agar or brain heart infusion agar supplemented with 5 to 10 percent carbon dioxide. M. bovis requires specialized media such as Friis medium or Hayflick's medium and incubation for 3 to 10 days under microaerophilic conditions [14, 15].

Colonial morphology, Gram stain characteristics, and biochemical profiles (oxidase, catalase, indole, urease) provide preliminary identification. Confirmatory identification and differentiation of M. haemolytica serotypes require additional testing. Culture-based methods are limited by low sensitivity in animals that have received antimicrobial therapy and by the overgrowth of commensal flora [16, 17].

Antimicrobial Susceptibility Testing

Antimicrobial susceptibility testing (AST) is critical for guiding therapy and monitoring resistance trends. Disk diffusion (Kirby-Bauer) and broth microdilution methods are standardized by the Clinical and Laboratory Standards Institute (CLSI) for veterinary pathogens. Minimum inhibitory concentration (MIC) breakpoints are established for M. haemolytica, P. multocida, and H. somni against antimicrobial agents commonly used in feedlot cattle including tetracyclines, macrolides, fluoroquinolones, and cephalosporins [18, 19].

Resistance to oxytetracycline, tilmicosin, and tulathromycin has been documented in M. haemolytica and P. multocida isolates from North American feedlots. The emergence of multidrug-resistant strains underscores the importance of routine AST surveillance in BRDC management programs [20, 21].

Molecular Detection Methods

Nucleic acid amplification technologies have transformed BRDC diagnostics by offering rapid, sensitive, and specific detection of bacterial pathogens directly from clinical specimens. Real-time polymerase chain reaction (qPCR) assays targeting species-specific genes including the leukotoxin gene (lktA) for M. haemolytica, the capsular biosynthesis gene (hyaD-hyaC) for P. multocida, and the 16S rRNA gene for H. somni are widely used in diagnostic laboratories [22, 23].

Multiplex qPCR panels that simultaneously detect the major BRDC bacterial and viral pathogens are commercially available and allow for comprehensive etiological profiling. These panels typically include M. haemolytica, P. multocida, H. somni, M. bovis, bovine respiratory syncytial virus, bovine parainfluenza virus type 3, bovine coronavirus, and bovine viral diarrhea virus [24, 25]. The detection of M. bovis by molecular methods is particularly advantageous due to the challenges associated with its culture.

Quantitative PCR can provide an estimate of bacterial load, which may correlate with disease severity. A study demonstrated that high nasopharyngeal loads of M. haemolytica (greater than 10^5 CFU equivalents per swab) were associated with an increased risk of subsequent BRDC diagnosis in feedlot cattle [26].

Serological Assays

Serological testing has limited utility for antemortem diagnosis of acute BRDC due to the delay in antibody production and the high background seroprevalence in cattle populations. However, serology is valuable for epidemiological studies and vaccine efficacy assessment. Enzyme-linked immunosorbent assays (ELISAs) for detecting antibodies against M. haemolytica leukotoxin, P. multocida capsular antigens, and H. somni outer membrane proteins are commercially available [27, 28]. Paired serum samples collected at the time of disease and 2 to 4 weeks later can demonstrate seroconversion, confirming recent infection. The diagnostic principles of ELISA are described in detail in Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus: p27 Antigen Detection and Diagnostic Interpretation, though the specific antigen targets differ for BRDC applications.

Metagenomic and Next-Generation Sequencing Approaches

Metagenomic sequencing using high-throughput sequencers represents an emerging approach for BRDC diagnostics. Shotgun metagenomics allows for the unbiased detection of all microbial DNA present in a clinical sample, including bacteria, viruses, fungi, and parasites. This approach has revealed a higher diversity of bacterial species in BRDC-affected lungs than previously recognized, including the detection of obligate anaerobes and unculturable organisms [29, 30].

Targeted amplicon sequencing of the 16S rRNA gene provides a culture-independent assessment of the respiratory microbiome. Studies using 16S sequencing have demonstrated that BRDC is associated with a shift from a diverse commensal community to a low-diversity, pathogen-dominated community, with M. haemolytica and P. multocida typically dominating [31, 32].

Whole genome sequencing (WGS) of bacterial isolates provides high-resolution typing, virulence gene profiling, and antimicrobial resistance gene identification. WGS-based prediction of antimicrobial resistance phenotypes shows good concordance with phenotypic AST for M. haemolytica and P. multocida, offering the potential for sequence-based resistance surveillance [33, 34].

Diagnostic Decision Tree

The following diagram illustrates a recommended diagnostic workflow for BRDC bacterial pathogen identification and antimicrobial stewardship.

flowchart TD
    A[Clinical Signs of BRDC: Fever, Depression, Dyspnea], > B{Sampling Method}
    B, > C[Live Animal: Deep Nasopharyngeal Swab or Bronchoalveolar Lavage]
    B, > D[Postmortem: Aseptic Lung Tissue Collection]
    C, > E[Primary Diagnostic Pathway]
    D, > E
    E, > F{Diagnostic Modality}
    F, > G[Conventional Culture on Blood Agar and MacConkey Agar]
    F, > H[Multiplex qPCR Panel for BRDC Pathogens]
    F, > I[16S rRNA Gene Sequencing or Metagenomics]
    G, > J[Identification: Colony Morphology, Gram Stain, Biochemical Tests]
    G, > K[Antimicrobial Susceptibility Testing by Broth Microdilution or Disk Diffusion]
    H, > L[Species Identification and Semiquantitative Bacterial Load Estimation]
    I, > M[Microbiome Profiling and Unbiased Pathogen Detection]
    J & K & L & M, > N{Interpretation}
    N, > O[Positive for Target Pathogen: Initiate Targeted Antimicrobial Therapy]
    N, > P[Negative or Mixed Flora: Consider Non-Bacterial Etiology or Sample Quality Issues]
    O, > Q[Monitor Clinical Response and Repeat Sampling if Refractory]
    P, > R[Investigate Viral, Fungal, or Parasitic Causes]
    K, > S[Resistance Detected: Adjust Antimicrobial Selection Based on MIC Profile]
    S, > Q

Comparison of Diagnostic Methods

The following table summarizes the key characteristics, advantages, and limitations of the major diagnostic approaches for BRDC bacterial pathogens.

Antimicrobial Stewardship Considerations

Diagnostic data should directly inform antimicrobial treatment decisions in BRDC management. Culture and AST results enable targeted therapy, reducing the use of broad-spectrum antimicrobials and mitigating selection pressure for resistant organisms. The implementation of rapid molecular diagnostics at the pen-side or within veterinary diagnostic laboratories facilitates early, pathogen-directed treatment [35, 36].

Metaphylactic antimicrobial use, the mass medication of high-risk cattle upon arrival at the feedlot, is a common practice that contributes to antimicrobial resistance development. Diagnostic surveillance programs that monitor pathogen prevalence and resistance profiles within a feedlot population can inform the rational selection of metaphylactic agents [37, 38]. The principles of antimicrobial stewardship in BRDC are consistent with those described in other livestock bacterial disease contexts, such as Streptococcus iniae and Lactococcus garvieae Infections in Farmed Fish: Detection and Antimicrobial Stewardship and Antimicrobial Resistance in Livestock-Associated Staphylococcus aureus: Genomic Epidemiology and One Health Implications.

Future Directions

The integration of diagnostic data with animal health records, environmental parameters, and management factors through computational models offers the potential for predictive algorithms that identify cattle at high risk for BRDC before clinical signs develop. Machine learning approaches using clinical and diagnostic input variables have shown promise in predicting BRDC outcome and treatment response [39, 40].

Point-of-care molecular diagnostic devices designed for field use could enable rapid, on-farm detection of BRDC pathogens and resistance markers. Lateral flow assays for antigen detection and isothermal amplification methods such as loop-mediated isothermal amplification (LAMP) for nucleic acid detection are under development for BRDC applications [41, 42].

Advanced imaging techniques, including computed tomography and thoracic ultrasound, provide non-invasive assessment of lung pathology and may complement microbiological testing in the evaluation of BRDC severity and treatment response [43, 44].

Conclusion

Accurate diagnosis of the bacterial component of BRDC is essential for effective case management and antimicrobial stewardship. Traditional culture-based methods remain valuable for AST, while molecular techniques including qPCR and metagenomic sequencing offer enhanced sensitivity, speed, and comprehensiveness. The choice of diagnostic approach depends on the clinical context, available resources, and specific objectives of testing, whether individual animal treatment guidance or population-level surveillance. Future developments in point-of-care testing and computational modeling will further refine diagnostic capabilities for this economically significant disease complex.

References

[1] Highlander SK. Molecular genetic analysis of virulence in Mannheimia haemolytica. Frontiers in Bioscience. 2001;6:D1128-D1150.

[2] Czuprynski CJ, Leite F, Sylte M, et al. Complexities of the pathogenesis of Mannheimia haemolytica infections: energy metabolism and virulence gene expression. Animal Health Research Reviews. 2004;5(2):117-122.

[3] Lo RY. Genetic analysis of virulence factors of Mannheimia haemolytica. Journal of Veterinary Medicine Series B. 2004;51(8-9):345-349.

[4] Dabo SM, Taylor JD, Confer AW. Pasteurella multocida and bovine respiratory disease. Animal Health Research Reviews. 2007;8(2):129-150.

[5] Harper M, Boyce JD, Adler B. Pasteurella multocida pathogenesis: 125 years after Pasteur. FEMS Microbiology Letters. 2006;265(1):1-10.

[6] Corbeil LB. Histophilus somni host-parasite relationships. Animal Health Research Reviews. 2007;8(2):151-160.

[7] Siddaramappa S, Challacombe JF, Duncan AJ, et al. Horizontal gene transfer and genome evolution in Histophilus somni. BMC Genomics. 2012;13:272.

[8] Tagawa Y, Sanders JD, Uchida I, et al. Role of the fibronectin-binding protein FbpA in adherence and biofilm formation by Histophilus somni. Infection and Immunity. 2005;73(9):5655-5663.

[9] Maunsell FP, Woolums AR, Francoz D, et al. Mycoplasma bovis infections in cattle. Journal of Veterinary Internal Medicine. 2011;25(4):772-783.

[10] Gardner BA, Dolczal HG, Bryant LK, et al. Health of finishing steers: effects on performance, carcass traits, and meat tenderness. Journal of Animal Science. 1999;77(12):3168-3175.

[11] Buczinski S, Forté G, Francoz D, et al. Comparison of thoracic auscultation, clinical score, and ultrasonography as indicators of bovine respiratory disease in preweaned dairy calves. Journal of Veterinary Internal Medicine. 2014;28(1):234-242.

[12] Caswell JL, Williams KJ. Respiratory system. In: Maxie MG, editor. Jubb, Kennedy, and Palmer's Pathology of Domestic Animals. 6th ed. Elsevier; 2016. p. 465-591.

[13] Guichon PT, Jim GK, Booker CW, et al. Relative economic value of serum urea nitrogen and serum total protein to predict health and performance of newly arrived feedlot steers. Canadian Veterinary Journal. 1993;34(9):545-551.

[14] Rosenbusch RF. Biology and pathogenicity of Mycoplasma bovis. Veterinary Clinics of North America: Food Animal Practice. 2010;26(2):273-284.

[15] Nicholas RA, Ayling RD. Mycoplasma bovis: disease, diagnosis, and control. Research in Veterinary Science. 2003;74(2):105-112.

[16] DeRosa DC, Mechor GD, Staats JJ, et al. Comparison of Pasteurella spp. and Mannheimia spp. from the upper and lower respiratory tracts of cattle with bacterial pneumonia. Journal of Veterinary Diagnostic Investigation. 2000;12(3):235-240.

[17] Allen JW, Viel L, Bateman KG, et al. The microbial flora of the respiratory tract in feedlot calves: associations between nasopharyngeal and bronchoalveolar lavage cultures. Canadian Journal of Veterinary Research. 1991;55(4):341-346.

[18] Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. 5th ed. CLSI document VET01. Wayne, PA: CLSI; 2020.

[19] Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. 5th ed. CLSI document VET08. Wayne, PA: CLSI; 2020.

[20] Portis E, Lindeman C, Johansen L, et al. A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex. Journal of Veterinary Diagnostic Investigation. 2012;24(4):649-656.

[21] Lubbers BV, Hanzlicek GA. Antimicrobial multidrug resistance and coresistance patterns of Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni from feedlot cattle. Journal of Veterinary Diagnostic Investigation. 2013;25(6):761-766.

[22] Angen O, Thomsen J, Larsen LE, et al. Respiratory disease in calves: microbiological investigations on trans-tracheally aspirated bronchoalveolar fluid. Acta Veterinaria Scandinavica. 2009;51:30.

[23] Turmi C, Böttcher J, Heppelmann M, et al. Detection of Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in bovine nasopharyngeal swabs by real-time PCR. Berliner und Münchener Tierärztliche Wochenschrift. 2011;124(5-6):202-209.

[24] Härtel H, Nikunen S, Neuvonen E, et al. Viral and bacterial pathogens in bovine respiratory disease in Finland. Acta Veterinaria Scandinavica. 2004;45(3-4):193-200.

[25] Pardon B, De Bleecker K, Dewulf J, et al. Prevalence of respiratory pathogens in diseased, non-vaccinated, routinely medicated veal calves. Veterinary Record. 2011;169(11):278.

[26] Taylor JD, Fulton RW, Lehenbauer TW, et al. The epidemiology of bovine respiratory disease: what is the evidence for predisposing factors? Canadian Veterinary Journal. 2010;51(10):1095-1102.

[27] Gagea MI, Bateman KG, van Dreumel T, et al. Diseases and pathogens associated with mortality in Ontario beef feedlots. Journal of Veterinary Diagnostic Investigation. 2006;18(1):18-28.

[28] Confer AW, Ayalew S. Mannheimia haemolytica in bovine respiratory disease: immunogens, potential immunogens, and vaccines. Animal Health Research Reviews. 2018;19(1):79-99.

[29] Holman DB, McAllister TA, Topp E, et al. The nasopharyngeal microbiota of feedlot cattle that develop bovine respiratory disease. Veterinary Microbiology. 2015;180(1-2):90-95.

[30] Timsit E, Workentine M, Schryvers AB, et al. Evolution of the nasopharyngeal microbiota of beef cattle from weaning to 40 days after arrival at a feedlot. Veterinary Microbiology. 2016;187:75-81.

[31] Holman DB, Timsit E, Amat S, et al. The nasopharyngeal microbiota of beef cattle before and after transport to a feedlot. BMC Microbiology. 2017;17(1):70.

[32] McMullen C, Orsel K, Alexander TW, et al. The nasopharyngeal microbiota of beef cattle at arrival at a feedlot and its association with subsequent bovine respiratory disease. Veterinary Microbiology. 2020;241:108571.

[33] Klima CL, Alexander TW, Hendrick S, et al. Characterization of Mannheimia haemolytica isolated from feedlot cattle. Journal of Veterinary Diagnostic Investigation. 2014;26(2):266-271.

[34] Owen JR, Noyes NR, Young AE, et al. Whole-genome sequencing and concordance between antimicrobial resistance genotypes and phenotypes in bacterial isolates of bovine respiratory disease. mSystems. 2017;2(3):e00064-17.

[35] Ives SE, Richeson JT. Use of antimicrobial metaphylaxis for the control of bovine respiratory disease in feedlot cattle. Veterinary Clinics of North America: Food Animal Practice. 2015;31(1):63-79.

[36] Abell CE, Theurer ME, Larson RL, et al. A mixed treatment comparison meta-analysis of metaphylaxis treatments for bovine respiratory disease in beef cattle. Journal of Animal Science. 2017;95(2):626-635.

[37] Cameron A, McAllister TA. Antimicrobial usage and resistance in beef production. Journal of Animal Science and Biotechnology. 2016;7:68.

[38] Benedict KM, Gow SP, McAllister TA, et al. Antimicrobial resistance in Escherichia coli recovered from feedlot cattle and associations with antimicrobial use. PLOS ONE. 2015;10(12):e0143995.

[39] Lhermie G, Gröhn YT, Raboisson D. Animal health and economics: a systematic review of methods for the assessment of the economic impact of bovine respiratory disease. Preventive Veterinary Medicine. 2017;146:105-115.

[40] White BJ, Anderson DE, Renter DG, et al. Clinical, behavioral, and pulmonary changes in calves following inoculation with Mannheimia haemolytica. American Journal of Veterinary Research. 2012;73(4):532-540.

[41] Poon LL, Wong BW, Ma EH, et al. Sensitive and inexpensive molecular test for detection of Mannheimia haemolytica in bovine respiratory disease. Journal of Clinical Microbiology. 2006;44(3):891-895.

[42] Ahmadi E, Haghkhah M, Badiei A, et al. Detection of Mannheimia haemolytica and Pasteurella multocida by loop-mediated isothermal amplification. Iranian Journal of Veterinary Research. 2017;18(1):37-42.

[43] Ollivett TL, Buczinski S. On-farm use of ultrasonography for bovine respiratory disease. Veterinary Clinics of North America: Food Animal Practice. 2016;32(1):19-35.

[44] Jung C, Große-Siestrup C, Becker K, et al. Computed tomography of bovine lungs. Veterinary Radiology and Ultrasound. 2005;46(3):214-220.

[45] Booker CW, Abutarbush SM, Morley PS, et al. Microbiological and histopathological findings in cases of bovine respiratory disease in feedlot cattle. Canadian Veterinary Journal. 2008;49(4):375-381.

[46] Corbeil LB. Immune responses to Histophilus somni. Animal Health Research Reviews. 2007;8(2):161-176.

[47] Gioia G, Addis MF, Carta P, et al. Genomic and phenotypic characterization of Mannheimia haemolytica strains from cattle. Veterinary Microbiology. 2020;242:108606.

[48] Noyes NR, Yang X, Linke LM, et al. Characterization of the resistome in bovine respiratory disease. mBio. 2016;7(2):e00118-16.

[49] Zaheer R, Cook SR, Barbieri R, et al. Metagenomic analysis of the bovine respiratory disease complex. Applied and Environmental Microbiology. 2021;87(5):e02685-20.

[50] Timsit E, Hallewell J, Booker CW, et al. Prevalence and antimicrobial susceptibility of Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolated from the nasopharynx of feedlot cattle. Canadian Journal of Veterinary Research. 2017;81(2):94-101.